Myrbetriq ER 50 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJJ08
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,177
Award facts
- Contract value 100% obligated
- $11,177.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $11,177.38. This is a firm fixed price delivery order with no set-aside designation, placing of performance at the vendor's Conshohocken, Pennsylvania headquarters. The award is issued as a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical commodities to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive delivery of pharmaceuticals across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. All of the company's reviewed contract awards have been competitively awarded without set-aside designations, reflecting its capability to meet federal procurement requirements through open competition. Through its DLA contracts, AmerisourceBergen Drug Corp provides pharmaceutical support to customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FJJ08?
SPE2DB25FJJ08 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FJJ08 worth?
The government has obligated $11,177 on SPE2DB25FJJ08.
Is contract SPE2DB25FJJ08 an order under another contract?
Yes. SPE2DB25FJJ08 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJJ08 competed?
The extent of competition for SPE2DB25FJJ08 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award